Inyección intraesfinteriana de toxina botulínica en pacientes con acalasia esofágica

Eight patients received 80 units of BoTx. Assessment of response was based on changes in the symptom scores (0-9) and esophageal manometric studies. Results: Six out of 8 patients (75 percent) had sustained clinical improvement after therapy. This effect was maintained for a mean time of 17.8 months. The symptom score decreased from a mean of 6.7 to 0.5 (p